What is a Clinical Trial?
The body's battlefield: exploring the world of clinical trials
A new treatment, a revolutionary therapy, holds the potential to change lives, offering hope and healing for millions. But before this revolutionary treatment can reach your loved ones, your neighbors, or even yourself, it must navigate a crucial battlefield: the world of clinical trials.
What exactly is a clinical trial? How does clinical research differ from medical research? How do researchers prevent bias and ensure their results are reliable? Is it safe to participate? And is clinical research actually worth the investment it demands? This guide answers all of these questions, and more.
What are clinical trials?
Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes. People volunteer to take part in clinical trials to test medical interventions, including drugs, cells, and other biological products; surgical procedures; radiological procedures; devices; behavioural treatments; and preventive care (World Health Organization (WHO).
Clinical trials are carefully designed, reviewed, and completed to evaluate the effectiveness and safety of new interventions in humans. They need to be approved before they can start. People of all ages can take part in clinical trials, including children.
According to the World Health Organization (WHO), an estimated 300,000 clinical trials are ongoing worldwide, with millions of participants contributing to the advancement of healthcare.
Clinical research encompasses a wide range of activities dedicated to understanding, preventing, and treating diseases. It’s the bridge between laboratory discoveries and real-world applications, translating scientific breakthroughs into tangible benefits for patients.
This research can involve various methods, including:
- Observational studies: These studies observe and analyze the health and behaviors of participants without administering any interventions.
- Interventional studies: These studies test new drugs, devices, or surgical procedures on human participants. This is where clinical trials come into play.
What is clinical research, and how does it differ from medical research?
These terms are often used interchangeably, but they are not the same thing.
Medical research is an umbrella term that encompasses any scientific investigation aimed at understanding human health, disease mechanisms, or biological processes. It includes basic science conducted entirely in laboratories, animal studies, computational modeling, and epidemiology. Medical research does not always involve human participants directly.
“Clinical research”, by contrast, specifically refers to research that involves human participants, either directly or through the use of human biological samples or health data. Clinical research is the stage at which scientific discoveries move out of the lab and into real-world testing with people. It is governed by strict ethical and regulatory frameworks, including the ICH GCP guidelines, to protect participant safety and ensure data integrity.
In practical terms, all clinical trials are clinical research, but not all clinical research are clinical trials. An observational study that follows a group of patients over time without administering any intervention is clinical research, but it is not a clinical trial. A randomized controlled trial testing a new drug is both clinical research and a clinical trial.
What are the aims of clinical research?
Clinical research serves several fundamental purposes, all of which ultimately aim to improve human health. The main aims of clinical research include:
- Evaluating the safety of new interventions: Before any drug, device, or treatment can be used in standard medical care, clinical research must confirm that it does not cause unacceptable harm to participants.
- Assessing efficacy: Clinical research determines whether an intervention actually works, that is, whether it produces the intended health benefit in the population it targets.
- Comparing treatments: Many clinical trials are designed to determine not just whether a new treatment works but also whether it works better than existing options, thereby raising the standard of care.
- Understanding disease mechanisms: Observational clinical research helps scientists understand how diseases develop, progress, and vary across different populations.
- Improving quality of life: Some clinical research focuses on interventions that may not cure a disease but can reduce symptoms, improve function, or enhance patients’ overall well-being.
- Generating regulatory data: Regulatory agencies such as the US FDA and the European Medicines Agency (EMA) require robust clinical research evidence before approving any new treatment for public use.
According to the WHO’s guidance for best practices in clinical trials, the ultimate goal is for trials to be reliably informative, ethical, and efficient, answering scientifically important questions relevant to the populations they are intended to benefit.
What is an example of clinical research?
One of the most well-known recent examples of clinical research is the development of COVID-19 vaccines. Across multiple phases of clinical trials, researchers enrolled tens of thousands of participants in randomized, double-blind, placebo-controlled studies to evaluate the safety and efficacy of candidate vaccines before any received regulatory authorization.
Another widely cited example is the Women’s Health Initiative, a large-scale set of clinical trials and observational studies that ran for over a decade and produced landmark findings about the risks and benefits of hormone therapy, dietary changes, and supplementation in postmenopausal women.
On a smaller scale, a single-site clinical trial at a teaching hospital testing whether a new wound care protocol reduces post-surgical infection rates is also clinical research. Clinical research spans the full spectrum, from small exploratory studies to massive global trials involving hundreds of sites and thousands of participants across multiple countries.
The four phases of a clinical trial journey
Clinical trials follow a highly structured process. They are carefully structured with distinct phases, each designed to answer specific questions about the intervention. This multiphase approach ensures scientific validity and ethical considerations.
Here’s a breakdown of the typical stages involved in a clinical trial, typically categorized into four phases:
-
Phase I trials:
This initial phase typically involves a small group of healthy volunteers (20–80) to assess the safety and dosage of the new intervention. Researchers closely monitor potential side effects and determine the appropriate dosage for further investigation.
-
Phase II trials:
If a treatment shows promise in Phase I, it progresses to Phase II, involving a larger group of patients (100–300) with the specific disease or condition the intervention targets. Researchers focus on evaluating the effectiveness of the intervention and identifying any side effects.
-
Phase III trials:
This phase involves a significantly larger participant pool (hundreds to thousands) across different locations to confirm the effectiveness of the intervention compared to the current standard treatment (if one exists). Additionally, Phase III trials gather more data on safety and potential long-term side effects.
-
Phase IV trials:
After a drug or device receives regulatory approval and becomes commercially available, Phase IV studies (also known as post-marketing surveillance studies) monitor its long-term effects and safety in real-world settings, often involving tens of thousands of participants.
Beyond the basics: the fascinating world of clinical trials
While the four-phase model serves as a general framework, clinical trials can take on a variety of structures:
-
Double-blind trials:
In these trials, neither the participants nor the researchers know who is receiving the intervention or the placebo, ensuring unbiased data collection.
-
Open-label trials:
Both participants and researchers are aware of which intervention is being administered. This approach can be helpful when investigating interventions that have well-established side effect profiles.
-
Randomized controlled trials (RCTs):
This gold standard of clinical research randomly assigns participants to receive the intervention or the control group, ensuring the most robust and generalizable results.
-
Adaptive trials:
These dynamic trials allow researchers to modify the study design as new information emerges, potentially accelerating the development process.
-
Platform trials:
These innovative trials test numerous potential interventions targeting the same disease, making efficient use of resources and participant time.
How clinical trials avoid bias: randomization, blinding, and placebo controls
One of the most important challenges in any clinical trial is ensuring that the results reflect the true effect of the intervention, not the expectations of participants or researchers, not chance imbalances between groups, and not errors in how outcomes are measured. Clinical trials use a combination of randomization, blinding, and placebo controls to address these risks.
Types of randomization in clinical trials
Randomization is the process by which participants are assigned to different treatment groups using a chance-based method rather than any deliberate selection by the researcher or the participant. The main types of randomization used in clinical trials include:
- Simple randomization: Each participant is assigned to a group based entirely on a random process, in principle similar to a coin flip. This method is straightforward but can produce unequal group sizes in smaller clinical trials.
- Block randomization: Participants are randomized in fixed-size groups, or “blocks,” to ensure that treatment group sizes remain approximately equal throughout the trial. This is one of the most commonly used methods in practice.
- Stratified randomization: Participants are first divided into subgroups (strata) based on characteristics that may affect outcomes, such as age, sex, or disease severity, and are then randomized within each stratum. This ensures that important baseline characteristics are balanced across treatment groups from the outset.
- Adaptive randomization: The probability of assignment to a particular treatment group changes during the trial based on accumulating data, to enroll more participants into the treatment that appears to be performing better. This method is often incorporated into adaptive trial designs.
The purpose of all randomization methods is the same: to reduce selection bias and ensure that any differences observed between groups at the end of the clinical trial are attributable to the treatment itself, not to pre-existing differences between participants. Understanding these methods is a core component of Good Clinical Practice training for all professionals working in clinical research.
How blinding prevents bias in clinical trials
Even after randomization, the behavior of participants and researchers can introduce bias into a clinical trial. A participant who knows they are receiving an experimental treatment may report improvement simply because of that expectation; this is the well-documented placebo effect. A researcher who knows which treatment a participant received may, even unconsciously, interpret borderline results in a direction that favors their hypothesis. Blinding addresses both of these risks.
- Single-blind trials: The participant does not know which treatment they are receiving, but the clinical team does. This eliminates participant expectation bias but does not prevent researcher bias.
- Double-blind trials: Neither the participant nor the clinical team administering the treatment and collecting the data knows who has been assigned to which group. Double-blind, randomized controlled trials are considered the gold standard of clinical evidence and sit at the top of the evidence hierarchy used by regulatory bodies worldwide.
- Triple-blind trials: Blinding is extended to include the statisticians and data analysts so that even the team running the final analysis does not know which data belong to which treatment group until the analysis is complete.
Blinding must be combined with proper allocation concealment, keeping the assignment sequence confidential until after each participant is enrolled, to fully protect against selection and performance bias in the clinical trial.
The role of placebo controls in clinical trials
A placebo is an inert substance or sham procedure that looks, feels, and is administered in the same way as the treatment under investigation, but contains no active ingredient. Placebos serve two essential functions in clinical trials.
First, they enable blinding. If participants in the control group receive nothing at all, they will immediately know they are not receiving the treatment, which breaks the blind and reintroduces expectation bias.
Second, placebos allow researchers to distinguish the true pharmacological or therapeutic effect of a treatment from the placebo effect — the measurable improvement in outcomes that occurs simply because a participant believes they are receiving an active treatment. Without a placebo comparator, it is impossible to know whether improvements seen in the treatment group reflect the treatment itself or simply the psychological benefit of being closely monitored and cared for.
It is important to note that clinical trials do not always use placebos. When an established effective treatment already exists for the condition being studied, it is generally considered unethical to withhold treatment by assigning participants to a placebo group. In those cases, the new intervention is compared to the existing standard of care. This reflects the ethical principles outlined in the Declaration of Helsinki, which governs the ethical conduct of medical research involving human subjects.
The unsung heroes of clinical trials: beyond the doctors
There’s a common misconception that clinical trials solely involve doctors. In reality, a dedicated team of professionals ensures the smooth operation and ethical conduct of these studies. This team includes:
-
Clinical research associates (CRAs):
CRAs are the backbone of clinical trials. They’re responsible for overseeing the day-to-day operations of a clinical trial, ensuring adherence to protocols, collecting data, ensuring its integrity, and maintaining accurate patient records .
-
Clinical trial managers:
They oversee all aspects of the trial, from budgeting and recruitment to data management and reporting.
-
Data managers:
They are responsible for collecting, cleaning, and managing clinical trial data, ensuring its accuracy and completeness.
-
Regulatory specialists:
These professionals navigate the complex regulatory landscape, ensuring the trial complies with all applicable laws and regulations.
-
Ethics committees:
These independent bodies review the ethical principles in the proposed clinical research and ensure the study protects participants’ well-being before they can proceed.
-
Investigators (doctors leading the research and their study team):
Lead researchers design and conduct the trial, interpreting data and drawing conclusions about the intervention’s effectiveness and safety. Principal investigators carry significant responsibilities under ICH GCP guidelines, from ensuring the protocol is followed to protecting the rights and safety of every enrolled participant. Our guide to principal investigator responsibilities explains this role in detail.
The ethical considerations: protecting patients and ensuring trust
The safety and well-being of participants are paramount in any clinical trial. Rigorous ethical guidelines are established and meticulously followed, including informed consent, participant confidentiality, and independent oversight by Institutional Review Boards (IRBs).
The ethical framework governing clinical research has developed over decades, from the foundational principles of the Nuremberg Code and the Belmont Report to the current Declaration of Helsinki 2024 and the ICH GCP E6(R3) guidelines. Together, these documents define the ethical standards that every sponsor, investigator, and clinical research professional must uphold in the conduct of clinical trials. Understanding and applying these principles is central to any good clinical practice certification program. For a detailed look at the informed consent requirements that protect clinical trial participants, see our guide to informed consent in clinical trials.
Beyond the basics: the untold stories of clinical trials
Many blog posts delve into the basic structure of clinical trials. However, there are fascinating aspects that often go unmentioned:
- The importance of patient recruitment: Finding eligible participants is a critical but often challenging aspect of clinical trials. Many trials face slow enrollment, which can delay research progress.
- The power of diversity: Including participants from diverse backgrounds within clinical trials is essential to ensure the generalizability of findings across various populations. Historically, minorities have been underrepresented in studies, leading to treatment approaches that might not be equally effective for all patients.
- The ethical considerations: Protecting participant safety and upholding informed consent are paramount in clinical research. Participants must understand the potential risks and benefits of an intervention before enrolling in a trial.
- The impact on global health: Clinical trials conducted in different countries can lead to breakthrough treatments accessible to a wider population. International collaboration and data sharing are essential to accelerate medical advancements.
Is it safe to participate in clinical studies?
This is one of the most common questions from people considering enrollment in a clinical trial, and it deserves a clear, honest answer.
Clinical trials carry genuine risks. Any experimental intervention may have unknown side effects, and participants in early-phase trials accept a higher level of uncertainty than those in later phases, where safety data already exists from prior studies. Potential risks include side effects from the investigational treatment, additional procedures, time commitments, and in some cases the possibility of receiving a placebo rather than an active treatment.
At the same time, clinical trials are subject to the most rigorous safety oversight of any medical procedure. Before a clinical trial can begin, it must be reviewed and approved by an independent ethics committee or Institutional Review Board (IRB), whose purpose is to protect participants. During the trial, ongoing safety monitoring occurs at multiple levels, including Data Safety Monitoring Boards (DSMBs) — independent expert committees that review accumulating safety data and have the authority to halt a clinical trial early if participants are being harmed.
Key protections that clinical trial participants are entitled to include:
- Informed consent: Participants must receive complete, understandable information about the clinical trial, including its purpose, procedures, potential risks and benefits, and their right to withdraw at any time — without penalty or loss of access to standard care.
- The right to withdraw: Participation in a clinical trial is always voluntary. Participants can leave at any time, for any reason.
- Independent ethics oversight: Every clinical trial must receive ethical approval before it can enroll a single participant.
- Regulatory compliance: Trials must comply with national and international regulations, including Good Clinical Practice guidelines.
- Ongoing safety monitoring: Safety reviews allow clinical trials to be modified or stopped early if unexpected risks emerge.
These protections are not theoretical — they are the direct result of decades of ethical and regulatory development. For professionals involved in setting up or running clinical trials, understanding these participant protections is a core component of ICH GCP training and Good Clinical Practice certification. If you are thinking about setting up a clinical trial site, our course on how to set up a clinical trial site covers the safeguards that must be in place before enrollment begins.
Is clinical research a waste of time and money?
It is a fair question — and one that is asked more often than the clinical research community sometimes acknowledges. Clinical research is expensive, time-consuming, and failure-prone. The majority of drugs that enter clinical trials never reach regulatory approval. Late-phase failures are common, even after years of prior development and substantial investment. So is the entire endeavor worth it?
The evidence strongly suggests that it is, but the argument is not simply about individual trials succeeding or failing.
The value of clinical research lies in its cumulative contribution to the evidence base of medicine. Even a clinical trial that fails to demonstrate that a new drug works provides valuable negative evidence, ruling out an avenue that might otherwise have consumed decades of further research. Every trial, successful or not, generates safety, pharmacological, and mechanistic data that can inform future research directions.
Moreover, the treatments that do emerge from clinical research have transformed medicine in measurable ways. Vaccines for infectious diseases, antiretroviral therapies that turned HIV from a death sentence into a manageable condition, cancer immunotherapies, and treatments for conditions that were previously untreatable, all of these are direct products of clinical trials. Without clinical research, standard medical care would still be based on tradition and expert opinion rather than robust evidence.
The efficiency challenges in clinical research are real, and they are increasingly being addressed. Adaptive trial designs, platform trials that test multiple interventions simultaneously, and improved international collaboration all contribute to faster, leaner, and more informative trials. The WHO’s updated guidance for best practices in clinical trials specifically advocates for risk-based, proportionate approaches to trial design and oversight that reduce unnecessary burden without compromising scientific rigor.
Clinical research is resource-intensive because the stakes, human health and safety, are extraordinarily high. The cost of failing to conduct rigorous clinical research is not paid by pharmaceutical companies. It is paid by patients who receive treatments that do not work, or that cause harm that a well-designed clinical trial would have detected before approval.
The power of participation: why clinical trials matter
Clinical trials play a vital role in driving medical advancements.
Participating in a clinical trial offers the opportunity to contribute directly to medical advancements. Individuals gain access to potential cutting-edge treatments before they become widely available and benefit from close medical monitoring throughout the study.
However, it’s crucial to note that clinical trials aren’t risk-free. Potential side effects can occur, and the intervention may not always be effective. Open communication between the doctor and subjects is essential.
Here are just a few reasons why they’re so important:
- Developing new treatments: These studies pave the way for the discovery and refinement of innovative drugs, vaccines, and medical devices.
- Improving existing treatments: Clinical trials allow researchers to compare current treatments with newer approaches to identify better ways to manage various health conditions.
- Enhancing patient care: Participation in clinical trials gives patients access to potential breakthroughs before they become widely available. They also contribute to a collective effort that benefits future generations.
- Building a stronger medical knowledge base: The data collected in clinical trials helps researchers understand the mechanisms of disease and develop more targeted treatment strategies.
- Free or reduced-cost healthcare: Participants often receive medications, diagnostics, and close medical monitoring at no cost or a significantly reduced cost.
- Enhanced patient-physician communication: Closer interaction with study staff fosters stronger communication between patients and their doctors.
- The opportunity to contribute to science: Being part of a clinical trial gives patients the unique experience of knowing they’re contributing to the advancement of medical science.
Key takeaways
- A clinical trial is a controlled research study that tests the safety and efficacy of new medical interventions, including drugs, devices, procedures, and behavioral treatments, in human participants.
- Clinical research includes all research involving human participants; clinical trials are a specific type of clinical research that involves a deliberate intervention assigned by the researchers.
- Medical research is broader than clinical research and includes laboratory and animal studies that do not involve human participants directly.
- The main aims of clinical research are to evaluate safety, assess efficacy, compare treatments, understand disease mechanisms, and generate data for regulatory approval.
- Clinical trials follow four phases: Phase I (safety and dosage), Phase II (efficacy and side effects), Phase III (large-scale confirmation against standard treatment), and Phase IV (post-marketing surveillance).
- Randomization, including simple, block, stratified, and adaptive methods, assigns participants to treatment groups by chance to eliminate selection bias.
- Blinding (single, double, or triple) prevents expectation bias from participants and researchers from distorting clinical trial results; double-blind randomized controlled trials are the gold standard of clinical evidence.
- Placebo controls enable blinding and allow researchers to separate the true pharmacological effect of a treatment from the placebo effect.
- Clinical trial participation carries real risks, but robust ethical and regulatory safeguards, including informed consent, ethics committee oversight, Data Safety Monitoring Boards, and ICH GCP compliance, protect participants at every stage.
- Clinical research is not a waste of resources: even trials that fail generate valuable evidence and contribute to the long-term advancement of medicine and patient safety.
Taking the next step in your clinical research journey
Clinical trials play a vital role in advancing healthcare, offering hope for improved patient care and future medical breakthroughs. As you delve deeper into this fascinating field, consider embarking on a career in clinical research. With the right training and skills, you can become an integral part of this quest for cures and contribute to shaping the future of medicine.
Ready to take the next step? Whether you’re a seasoned professional or a novice in the field of clinical research, PharmaEduCenter’s Good Clinical Practice training caters to your specific needs and aspirations. Our courses delve into the intricacies of ICH GCP guidelines, equipping you with the knowledge and expertise to conduct ethical and compliant clinical trials. Explore our comprehensive Good Clinical Practice training.
As the ICH GCP guidelines evolve, you can rest assured that our dynamic learning system will keep you abreast of the latest changes. Our commitment to continuous learning ensures that you remain at the forefront of clinical research practices.
With PharmaEduCenter, you can advance your career and make a positive impact on the development of life-saving therapies. Embark on your journey of GCP excellence and obtain your Good Clinical Practice certification today!
Explore our full range of GXP training courses, including our ICH GCP E6(R3) Good Clinical Practice certification course, approved by TransCelerate Biopharma and accredited by the Faculty of Pharmaceutical Medicine (UK), and our specialized ICH GCP training for investigators and site personnel. Whether you are preparing for your first ICH GCP certification, refreshing your knowledge, or deepening your understanding of the fundamentals of clinical trials, PharmaEduCenter has a course designed for you.
FAQ: clinical trials
What is the difference between a clinical trial and a clinical study?
The terms are often used interchangeably, but they have a technical distinction. A clinical trial specifically involves an intervention, and participants are assigned to receive a treatment, procedure, or device. A clinical study is a broader term that includes both interventional studies (clinical trials) and observational studies, in which researchers observe participants without assigning them to a specific treatment.
How long does a clinical trial last?
The duration of a clinical trial varies significantly depending on the phase and the condition being studied. Phase I trials may last only a few months. Phase III clinical trials for chronic or long-term conditions can run for several years. Some Phase IV post-marketing surveillance studies continue for a decade or more.
Who can participate in a clinical trial?
Each clinical trial has specific eligibility criteria, called inclusion and exclusion criteria, that determine who can participate. These may relate to age, sex, type and stage of disease, previous treatments, and other health factors. Some clinical trials enroll healthy volunteers; others enroll people with specific conditions.
What is a randomized controlled trial (RCT)?
A randomized controlled trial (RCT) is a type of clinical trial in which participants are randomly assigned to either the treatment group (receiving the intervention being tested) or the control group (receiving the standard treatment or a placebo). The RCT is widely regarded as the gold standard of clinical evidence because randomization eliminates selection bias and blinding minimizes expectation bias from both participants and researchers.
What does it mean when a clinical trial is double-blind?
A double-blind clinical trial is one in which neither the participant nor the clinical team administering the treatment knows who has been assigned to which treatment group. This prevents both the participant’s expectations and the researcher’s assumptions from influencing how results are recorded and interpreted, producing the most unbiased possible evidence.
Is it safe to be in a clinical trial?
Clinical trials involve real risks, which vary depending on the phase and type of intervention. However, every approved clinical trial includes mandatory informed consent, independent ethics committee oversight, and ongoing safety monitoring. Participants always have the right to withdraw at any time. For a detailed discussion of participant protections, see the section “Is it safe to participate in clinical studies?” above.
What is the difference between medical research and clinical research?
Medical research encompasses all scientific investigation related to human health, including laboratory and animal studies that do not involve human participants. Clinical research is a subset of medical research that specifically involves human participants. Clinical trials are a specific type of clinical research in which participants are assigned to receive an intervention that is evaluated against a control condition.
What are Good Clinical Practice (GCP) guidelines, and do I need GCP training?
Good Clinical Practice (GCP) is an international set of ethical and scientific quality standards for designing, conducting, recording, and reporting clinical trials involving human participants. The most widely used version is the ICH GCP guideline E6(R3). Compliance with GCP is mandatory for all clinical research professionals, and GCP certification is a recognized and widely required professional qualification. Whether you work as an investigator, a clinical research associate, a study coordinator, or in a sponsor or CRO team, ICH GCP training is the essential foundation of your role.
